Suzhou, China

Xiaolei Wang


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:

goldMedal1 out of 832,761 
Other
 patents

Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Xiaolei Wang in Bacterial Infection Treatment

Introduction

Xiaolei Wang is an innovative inventor based in Suzhou, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds aimed at treating bacterial infections. His work focuses on the creation of novel mannose derivatives that have potential therapeutic applications.

Latest Patents

Xiaolei Wang holds a patent for a "2-alkynylmannose derivative and application thereof." This patent describes a structure that includes mannose derivatives, along with pharmaceutically acceptable salts, isotopes, and isomers. The compounds are designed for the treatment or prevention of bacterial infections. The patent also outlines the formulation of pharmaceutically acceptable compositions that incorporate these compounds for effective therapeutic use.

Career Highlights

Throughout his career, Xiaolei Wang has demonstrated a strong commitment to advancing pharmaceutical research. His innovative approach to developing mannose derivatives showcases his expertise in the field. With a focus on practical applications, he aims to address pressing health challenges related to bacterial infections.

Collaborations

Xiaolei Wang collaborates with Jiyue Zheng, who is also involved in research related to pharmaceutical applications. Their partnership enhances the potential for innovative solutions in the treatment of bacterial infections.

Conclusion

Xiaolei Wang's contributions to the field of pharmaceutical chemistry, particularly through his patent on 2-alkynylmannose derivatives, highlight his role as a key innovator in the fight against bacterial infections. His work continues to pave the way for new therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…